Study: Pelvic Mesh No More Effective than Standard Repair Technique
- Last Updated: July 27th, 2023
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Study: Pelvic Mesh No More Effective than Standard Repair Technique
A study conducted by researchers at the University of Aberdeen (Scotland) has found that pelvic organ prolapse repairs reinforced by non-absorbable synthetic mesh are no more effective than standard native tissue repair.
The results of the study were published recently in the medical journal The Lancet.
The PROSPECT study, a national collaborative research project involving 1348 women, is the largest randomized trial of the use of mesh in transvaginal prolapse surgery.
Researchers determined that the mesh, inserted through the vagina, resulted in a number of complications but did not offer any clear benefits, and concluded that the use of pelvic mesh in such procedures could be considered an “unnecessary risk,” until further research is conducted.
Table of Contents
What is Pelvic Mesh?
Pelvic mesh made of polypropylene is used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
First introduced to the market in the mid-1990s, the pelvic mesh is implanted transvaginally (through the vagina) and was first approved by the FDA under a 501(k) process based on a similarity to other mesh products already on the market.
As a result, many transvaginal mesh products were approved before they were ever tested on humans.
Pelvic Mesh Lawsuits
Millions of women have had transvaginal mesh surgery and many procedures have resulted in severe and sometimes permanent injury.
Pelvic mesh lawsuits allege that the device has a defective design that erodes the surrounding tissue, leads to excessive scar tissue growth, and is difficult to remove if it does not work properly.
In one recent lawsuit, Boston Scientific, the manufacturer of the pelvic mesh product Obtryx, failed in its effort to appeal awards totaling $18.5 million awarded to four different women.
The company was ordered to pay each plaintiff up to $4.25 million in compensatory damages for injuries related to the Obtryx mesh.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
